News
According to GlobalData’s Innovation Radar report, “AI Chips – Trends, Market Dynamics and Innovations,” the global AI chip ...
The construction sector is recognising the potential of AI to revolutionise processes across the project lifecycle ...
Pfizer and Astellas’ Xtandi (enzalutamide) has improved overall survival (OS) in patients with nmHSPC, but only as a combination therapy.
With clinical trials under pressure, industry leaders say it’s time for reform, digital transformation, and more patient-centric models.
Nvidia’s historic $4 trillion market cap highlights AI chip sector’s central role in tech supremacy.
10h
Healthcare Asia Magazine on MSNIndia’s TMVR market to grow 17% annually through 2036The country represented 10% of the Asia-Pacific market in 2024. India’s transcatheter mitral valve repair (TMVR) market is ...
The world’s 20 largest publicly listed insurers reported an average year-on-year premium growth of 6.8% in 2024, according to a new analysis by GlobalData. This performance was attributed to higher ...
The mRNA therapeutics field is rapidly evolving beyond vaccines to include treatments for cancer, genetic disorders and in vivo cell therapies, bringing with it diverse production challenges. As the ...
The US dominates overall market sales, yet GlobalData research indicates that China is shaping up to be a formidable presence ...
Nvidia briefly became the first publicly-traded company in history to reach a market capitalisation of $4-trillion yesterday (9 July), outpacing tech giants Apple and Microsoft, and marking a pivotal ...
To underscore his point, Von Ahlen shared a few charts that he said investors should be paying attention to right now. These charts help to highlight some of the disconnects between the economic data, ...
While progress on the Trump tariffs is being made, “the underlying drivers of de-globalisation are inexorable.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results